Validation of the HAPPI Kids Continuous Age-Specific Pediatric Reference Intervals

Monsurul Hoq1,2, Susan Matthews3,4, Vicky Karlaftis1

  • 1Murdoch Children's Research Institute, Parkville, Australia.

Insights

This study successfully validated HAPPI Kids continuous reference intervals (RIs) for pediatric biochemistry analytes in a routine laboratory setting. The findings confirm the applicability of these RIs, ensuring accurate patient care and laboratory accreditation.

Area of Science:

  • Clinical Biochemistry
  • Laboratory Medicine
  • Pediatric Diagnostics

Background:

  • Appropriate reference intervals (RIs) are crucial for accurate patient care and must align with population demographics and laboratory methods.
  • Current Clinical and Laboratory Standard Institute (CLSI) guidelines lack specific recommendations for validating continuous RIs.

Purpose of the Study:

  • To validate the recently published HAPPI Kids continuous RIs within a routine laboratory environment.
  • To assess the applicability of HAPPI Kids RIs across different laboratory settings and analytical platforms.

Main Methods:

  • Compared test results between a primary study laboratory and a routine laboratory using specimens from 77 children.
  • Validated HAPPI Kids RIs using 279 pediatric samples on a Siemens ADVIA 1800 or Centaur/XP/XPT analyzer.
  • Applied a 90% acceptance criterion for results falling within the established RIs.

Main Results:

  • Minimal clinically significant differences were observed between the primary and routine laboratories.
  • The HAPPI Kids continuous RIs were validated for 16 of 18 biochemistry analytes after initial analysis.
  • The remaining 2 analytes were validated after secondary analysis, confirming the RIs' robustness.

Conclusions:

  • The HAPPI Kids RIs are validated for use in routine laboratories, meeting accreditation requirements.
  • This study proposes a modified CLSI method for continuous RI validation, benefiting clinical laboratories.
  • The validation ensures reliable pediatric biochemistry testing and supports informed clinical decision-making.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
154
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
177
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
114
Guidelines For Measuring Vital Signs01:19

Guidelines For Measuring Vital Signs

Following these guidelines can help nurses accurately measure vital signs, assess changes in patient conditions, and provide timely treatment when necessary. Adhering closely to the guidelines ensures the accuracy and reliability of the results.
Before taking a patient's vital signs, a nurse would consider and assess the patient's comfort level and ensure appropriate equipment is available.
2.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
148